The verdict on whether electronic cigarettes are safer than traditional cigarettes is still very much out. However, a recent study found e-cigarette emissions contain a variety of concerning chemicals, including some considered to be probable carcinogens.
Manufacturers who market their products as “BPA-free” aren’t just sending consumers a message about chemical composition. The underlying message is about safety — as in, this product is safe or least more safe than products that do contain BPA. However earlier this month, another study found that a common BPA alternative — BPS — may not be safer at all.
In a recent study, Harvard public health researchers decided to test a few dozen types of electronic cigarettes for diacetyl, a flavoring chemical associated with a severe respiratory disease known as “popcorn lung.” The researchers found diacetyl in a majority of the e-cigarettes they tested. News outlets jumped on the findings, with some announcing that e-cigarettes could cause the often-debilitating respiratory disease.
The Centers for Disease Control and Prevention recently released the first nationally representative estimates of electronic cigarette use among U.S. adults, finding that more than 12 percent had ever tried the aerosol nicotine products in 2014. So, as is the unfortunate case with many emerging and potential public health threats, it seems like e-cigarette use is outpacing the ability of regulatory bodies to protect the public’s health and educate consumers about possible risks.
In just a year, electronic cigarette use has tripled among American teens. And considering that no one really knows what the related health impacts are and any regulatory framework is lagging far behind the growing popularity of e-cigarettes, public health advocates say it’s time for action.
When the U.S. Food and Drug Administration approved the first vaccine to protect against cancers caused by certain strains of the human papillomavirus, or HPV, public health advocates cheered its life-saving potential. Unfortunately, the new vaccine quickly became embroiled in a debate over whether immunizing young girls against HPV, a sexually transmitted disease, would lead to risky sexual behavior.
Last week, the US Food and Drug Administration published a final rule that updates requirements for what prescription-drug information must disclose about potential effects for pregnant and breastfeeding women and their babies. And last month, the agency released Drug Trials Snapshots, which is part of a pilot project to help consumers learn more about the clinical trials upon which new drugs' approvals are based.
That people who work nights have their sleep cycles thrown out of balance has serious consequences but urging a potentially habit-forming, psychoactive drug on an economically stressed, overworked workforce, would seem to be a symptom, at the minimum, of a pharmaceutical industry gone awry. Shouldn’t we instead be figuring out how to reduce the occupational health risks of work schedules?
The Washington Post provides in-depth coverage on issues facing veterans who served in Iraq and Afghanistan; an unprecedented release of Medicare data gives reporters a lot to work with; and journalists consider how West Virginia's reliance on a few industries has influenced the state's response to contaminated water and drug addiction.
When President Obama signed the Food Safety Modernization Act into law in 2011, it was described as the most sweeping reform of the nation’s food safety laws in nearly a century. Public health advocates hailed the law for shifting regulatory authority from reaction to prevention. What received less attention was a first-of-its-kind provision that protects workers who expose food safety lawbreakers.